annb0t
Top 20
ResMed Inc.
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents.
In June 2021, NYU filed a complaint for patent infringement against ResMed in the United States District Court, District of Delaware. NYUâs complaint alleged that the AutoSetTM and AutoRampTM...
>>> Read more: ResMed Secures Significant Victory in Patent Fight Against New York University
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents.
In June 2021, NYU filed a complaint for patent infringement against ResMed in the United States District Court, District of Delaware. NYUâs complaint alleged that the AutoSetTM and AutoRampTM...
>>> Read more: ResMed Secures Significant Victory in Patent Fight Against New York University
